Dr. George Hajishengallis, D.d.s., Ph.d., Principal Investigator.dr. Hajishengallis Has a Longstanding Interest Long-standing Interest in Immune Regulation and Tissue Homeostasis in Periodontal Diseas
Intelligence Specialist
Support Operations Coordinator
Clinical Laboratory Regulatory Specialist
Physician - Radiology Diagnostic
Dietitian (Clinical)
Pregnancy and Early Childhood: Performance Management Process Needed for Three Programs
CAREER: Toward Guaranteed Reliability in AI-Enabled Robotic Teleoperation Through Formal Logic and Certification
Artificial Intelligence: Uses and Risks for Small Business Contracting and Innovation Research
Conference: Support for 2026 Phytochemical Society of North America (PSNA) Conference PSNA's 65th annual meeting, University of Wisconsin-Madison on June 15-19, 2026.
Doxorubicin Is a Very Effective Chemotherapy That Is Routinely Prescribed for the Treatment of Various Cancers, but Its Use Is Limited Because of Its Potential to Cause Cardiotoxicity. One Mechanism
Regulation of nucleus accumbens microcircuitry by exogenous opioid exposure
Extended Amygdala Arousal Circuitry and Alcohol-Induced Sleep Disruption
Novel Mechanisms of Protection from Substance Abuse Drugs
Clean Water Act: Corps of Engineers Has Improved Oversight of Compensatory Mitigation, but Needs Implementation Guidance
Aviation Workforce: FAA Could Strengthen Regional Pilot Pipeline by Establishing Timelines for Training Initiatives
This Grant Applies $5,365,214 of Ffy 2022 Section 5339(c) Low or No Discretionary for Mdot to Perform the Following Activities on the Island of Maui. A) Acquire New Replacement Hybrid Electric Buses
Federal Employees Health Benefits Program: Additional Actions Needed to Address Significant Risks in Verifying Provider Eligibility
The Sanford Burnham Prebys Medical Discovery Institute, Under the Direction of Dr. Changlu Liu, Will Be Primarily Responsible for the Identifying the Gpr25 Ligand, Which Included the Work Outlined in
The Main Goal of the Current Proposal Is to Decipher the Multifactorial Trajectories and the Biological Basis That Lead to Late Onset Dementia. We Have Identified N=556 Subjects With Age > 60 Years at
100
40
50
10
100
Moderate opportunity — established market with selective entry points.